- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02233283
Effect of Modifications of Nutritional Intake Upon Reproductive Hormones in Normal Women (Polynut)
Effect of Metabolic Variations Upon the Activity of the Neuroendocrine Reproductive Axis in Normal Female Volunteers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the present study, the investigators will perform a very detailed study of the minute to minute regulation of hormones of the neuroendocrine reproductive axis in normal young female volunteers. These studies will initially be performed at base line during isocaloric diet, where the stimulation of LH secretion by exogenous insulin will be tested during hyperinsulinemic eugylcemic clamp studies.
The same studies will then be repeated after a period of one month of controlled hypercaloric diet, where volunteers will receive an excess of approximately 30% KCal compared to their calculated daily energy expenditure. it is anticipated that such hypercaloric nutrition will induce a significant decrease in normal insulin sensitivity of these volunteers. Thus, the effect of changing whole body insulin sensitivity on the fine regulation of neuroendocrine reproductive hormones will be evaluated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Clinical Research Center, University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
normally cycling young (between 18 and 30 yo) female, with a BMI between 20 and 25 kg/m2.
-
Exclusion Criteria:
- Personal history of endocrine dysfunction (any kind)
- Hormonal contraception
- Pregnancy
- Food allergy (any kind)
- Intense physical activity (>4 hrs/week)
- Smoking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hypercaloric diet and basal
Volunteers fed a hypercaloric diet for one month will be submitted to a fasting period of ten hours duration
|
Hypercaloric diet will be conducted during one month, and designed to provide 30% excess in calories compared to daily requirements.
It will consist in a high fat, high carbohydrates diet.
Other Names:
Keeping the volunteers in the fasting state overnight and for the entire duration of the experiment (10 hours)
Other Names:
|
|
Experimental: Hypercaloric diet and clamp
Volunteers fed a hypercaloric diet for one month will be submitted to a hyperinsulinemic and euglycemic clamp of ten hours duration
|
Hypercaloric diet will be conducted during one month, and designed to provide 30% excess in calories compared to daily requirements.
It will consist in a high fat, high carbohydrates diet.
Other Names:
Volunteers will be submitted to hyperinsulinemic, euglycemic clamp studies of 10 hours duration.
Other Names:
|
|
Active Comparator: Isocaloric diet and basal
Volunteers fed a isocaloric diet for one month will be submitted to a fasting period of ten hours duration
|
Keeping the volunteers in the fasting state overnight and for the entire duration of the experiment (10 hours)
Other Names:
Isocaloric diet will conducted for one month, and designed to provide the calculated daily energy needs
Other Names:
|
|
Experimental: Isocaloric diet and clamp
Volunteers fed a isocaloric diet for one month will be submitted to a hyperinsulinemic and euglycemic clamp of ten hours duration
|
Volunteers will be submitted to hyperinsulinemic, euglycemic clamp studies of 10 hours duration.
Other Names:
Isocaloric diet will conducted for one month, and designed to provide the calculated daily energy needs
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Luteinizing hormone secretion
Time Frame: Every ten minutes for 10 hours
|
The pulsatility of LH will be assessed by measuring LH levels in blood sample obtained every ten minutes over the entire study period (12 hours).
|
Every ten minutes for 10 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin sensitivity
Time Frame: 10 hours
|
Insulin sensitivity will be defined as the rate of glucose infusion required to maintain euglycemia during the hyperinsulinemic clamp
|
10 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Francois P Pralong, MD, Centre Hospitalier Universitaire Vaudois
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 43/13
- 320030_141065 (Other Grant/Funding Number: Swiss National Science Foundation)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female Reproductive System Disorder
-
University Hospital, ToulouseTerminatedFemale Reproductive Problem | Male Reproductive ProblemsFrance
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
Pennington Biomedical Research CenterCompletedFemale Reproductive Problem | Male Reproductive ProblemUnited States
-
Chung Shan Medical UniversityUnknownA Comparison of Clinical Outcomes of Warmed Embryo Vitrified at 2PN Stage and Fresh Embryo TransfersInfertility, Female | Reproductive DisorderTaiwan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingMalignant Female Reproductive System NeoplasmUnited States
-
Seoul National University Bundang HospitalUnknownMalignant Female Reproductive System NeoplasmKorea, Republic of
-
Centre Hospitalier Universitaire de NiceCompletedReproductive DisorderFrance
-
Nanjing UniversityRecruitingMVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive TechnologyInfertility, Female | IVF | Reproductive Disorder | OocyteChina
-
Liu WeifengNanfang Hospital of Southern Medical University; Second Affiliated Hospital... and other collaboratorsCompletedBenign Female Reproductive System NeoplasmChina
-
Queensland Centre for Gynaecological CancerCompletedFemale Reproductive ProblemAustralia
Clinical Trials on Hypercaloric diet
-
Rigshospitalet, DenmarkCompleted
-
Maimónides Biomedical Research Institute of CórdobaCompleted
-
Amsterdam UMC, location VUmcAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)CompletedObesity | Insulin Resistance | Type 2 DiabetesNetherlands
-
Université de SherbrookeHospices Civils de LyonCompleted
-
Centre Hospitalier Universitaire VaudoisUniversity of LyonUnknownObesity | DiabetesSwitzerland
-
George Washington UniversityTerminatedAdiposity | Impaired Glucose Tolerance | Insulin Sensitivity | Metabolic DisturbanceUnited States
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Maimónides Biomedical Research Institute of CórdobaCompleted
-
Luis GuerraInstituto de Salud Carlos IIICompleted
-
Maimónides Biomedical Research Institute of CórdobaActive, not recruiting